Test Your HER2 IQ

 
  • First Name:
    Last Name:
    Institution:
    Address 1:
    Address 2:
    City:
    State/Province:
    Zip/Postal:
    Email:
    What is your role in the breast cancer community?:
    I want to receive: Periodic information about new oncology products and services from Abbott Molecular.
    Test ID

    Initiate Quiz Process Form

    Welcome to the PathVysion Test Your HER2 IQ

    To begin, please fill out the short registration form, and then begin the quiz.

    There are 7 questions.


     
Questions you answered incorrectly in magenta below:
  1. What is HER2?
    A gene that regulates normal cell growth and function
    HER2 is a gene that regulates normal cell growth and function. However, abnormally high quantities of the HER2 gene have been associated with rapid tumor cell growth, resistance to therapy, and shorter disease free periods and overall survival. This type of cancer is called HER2 positive breast cancer.
  2. Why is it important to know your HER2 status?
    Your HER2 status is an essential piece of information that your physician uses to select appropriate therapy
    Knowing your HER2 status helps guide doctors to make the most appropriate therapy decisions. The PathVysion HER2 test is a vital tool used in the fight against breast cancer and provides physicians, pathologists and patients with accurate and reliable HER2 results.
  3. Why is PathVysion, which employs FISH technology, the best test for determining your HER2 status?
    All of the above
    All of the Above. PathVysion is approved by the FDA and has been proven as the best test for assessing HER2 status.
  4. Which women with breast cancer should be tested with the PathVysion HER2 test?
    All women should be tested at time of diagnosis and recurrence of breast cancer
    All women should be tested to determine their HER2 status. The National Comprehensive Cancer Network (NCCN®) and The American Society of Clinical Oncologists
  5. Why is the PathVysion HER2 test, which employs FISH technology, superior to ImmunoHistoChemistry (IHC) test?
    The protein measured by IHC can be damaged during preparation of the tissue sample and this may cause variability in outcome
    The protein measured by IHC can be damaged during preparation of the tissue sample and this may cause variability in outcome. Whereas, The PathVysion HER2 test is a stable gene-based, objective assessment that helps to positively identify women who are candidates for HER2-targeted therapies. To learn about the additional advantages that PathVysion provides, visit HER2 Testing Options - Why FISH technology is important.
  6. If I have already had a biopsy, I have to return to my doctor to have an additional biopsy to be HER2 tested.
    FALSE
    FALSE. Your HER-2 results can be obtained from your biopsy tissue, at any time, by using the PathVysion test. Because the test measures the HER2 gene at the stable DNA molecular level, results can be obtained from stored tissue samples. To learn about the PathVysion HER2 test, visit Why PathVysion is Right for You.”
  7. If I am diagnosed with breast cancer, I should ask to be tested with the PathVysion HER2 test, which has been proved to accurately and reproducibly assess tumors for HER2 status.
    TRUE
    TRUE. Not all physicians, pathologists or laboratories assess HER2 status using the PathVysion HER2 test. Be sure to specify with your doctor that you want to be tested with the PathVysion HER2 test. To learn about other topics to ask you doctor, visit Talking With Your Doctor.